IBDEI15I ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41848,1,3,0)
 ;;=3^Nonrheum Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,41848,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,41848,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,41849,0)
 ;;=I35.1^^159^2051^13
 ;;^UTILITY(U,$J,358.3,41849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41849,1,3,0)
 ;;=3^Nonrheum Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,41849,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,41849,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,41850,0)
 ;;=I35.2^^159^2051^14
 ;;^UTILITY(U,$J,358.3,41850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41850,1,3,0)
 ;;=3^Nonrheum Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,41850,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,41850,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,41851,0)
 ;;=I35.8^^159^2051^11
 ;;^UTILITY(U,$J,358.3,41851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41851,1,3,0)
 ;;=3^Nonrheum Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,41851,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,41851,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,41852,0)
 ;;=I35.9^^159^2051^12
 ;;^UTILITY(U,$J,358.3,41852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41852,1,3,0)
 ;;=3^Nonrheum Aortic Valve Disorders,Unspec
 ;;^UTILITY(U,$J,358.3,41852,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,41852,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,41853,0)
 ;;=I48.91^^159^2051^5
 ;;^UTILITY(U,$J,358.3,41853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41853,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,41853,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,41853,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,41854,0)
 ;;=I49.9^^159^2051^6
 ;;^UTILITY(U,$J,358.3,41854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41854,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,41854,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,41854,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,41855,0)
 ;;=I50.9^^159^2051^8
 ;;^UTILITY(U,$J,358.3,41855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41855,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,41855,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,41855,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,41856,0)
 ;;=I73.9^^159^2051^16
 ;;^UTILITY(U,$J,358.3,41856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41856,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41856,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,41856,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,41857,0)
 ;;=I87.2^^159^2051^18
 ;;^UTILITY(U,$J,358.3,41857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41857,1,3,0)
 ;;=3^Venous Insufficiency,Chronic,Peripheral
 ;;^UTILITY(U,$J,358.3,41857,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,41857,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,41858,0)
 ;;=R07.9^^159^2051^7
 ;;^UTILITY(U,$J,358.3,41858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41858,1,3,0)
 ;;=3^Chest Pain,Unspec
 ;;^UTILITY(U,$J,358.3,41858,1,4,0)
 ;;=4^R07.9
 ;;^UTILITY(U,$J,358.3,41858,2)
 ;;=^5019201
 ;;^UTILITY(U,$J,358.3,41859,0)
 ;;=E03.9^^159^2052^19
 ;;^UTILITY(U,$J,358.3,41859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41859,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,41859,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,41859,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,41860,0)
 ;;=E11.9^^159^2052^11
 ;;^UTILITY(U,$J,358.3,41860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41860,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,41860,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,41860,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,41861,0)
 ;;=E10.9^^159^2052^7
 ;;^UTILITY(U,$J,358.3,41861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41861,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,41861,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,41861,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,41862,0)
 ;;=E11.65^^159^2052^9
 ;;^UTILITY(U,$J,358.3,41862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41862,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,41862,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,41862,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,41863,0)
 ;;=E10.65^^159^2052^5
 ;;^UTILITY(U,$J,358.3,41863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41863,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,41863,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,41863,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,41864,0)
 ;;=E11.8^^159^2052^8
 ;;^UTILITY(U,$J,358.3,41864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41864,1,3,0)
 ;;=3^Diabetes Type 2 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,41864,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,41864,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,41865,0)
 ;;=E10.8^^159^2052^4
 ;;^UTILITY(U,$J,358.3,41865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41865,1,3,0)
 ;;=3^Diabetes Type 1 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,41865,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,41865,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,41866,0)
 ;;=E53.8^^159^2052^30
 ;;^UTILITY(U,$J,358.3,41866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41866,1,3,0)
 ;;=3^Vitamin B Group Deficiency
 ;;^UTILITY(U,$J,358.3,41866,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,41866,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,41867,0)
 ;;=E78.5^^159^2052^18
 ;;^UTILITY(U,$J,358.3,41867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41867,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,41867,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,41867,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,41868,0)
 ;;=E66.9^^159^2052^27
 ;;^UTILITY(U,$J,358.3,41868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41868,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,41868,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,41868,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,41869,0)
 ;;=E66.01^^159^2052^25
 ;;^UTILITY(U,$J,358.3,41869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41869,1,3,0)
 ;;=3^Morbid Obesity d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,41869,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,41869,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,41870,0)
 ;;=E66.3^^159^2052^28
 ;;^UTILITY(U,$J,358.3,41870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41870,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,41870,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,41870,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,41871,0)
 ;;=D50.9^^159^2052^20
 ;;^UTILITY(U,$J,358.3,41871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41871,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,41871,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,41871,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,41872,0)
 ;;=D64.9^^159^2052^2
 ;;^UTILITY(U,$J,358.3,41872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41872,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,41872,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,41872,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,41873,0)
 ;;=D68.318^^159^2052^17
 ;;^UTILITY(U,$J,358.3,41873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41873,1,3,0)
 ;;=3^Hemor d/o,Intrn Circ Anticoag,Antib,Inhb
 ;;^UTILITY(U,$J,358.3,41873,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,41873,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,41874,0)
 ;;=R50.9^^159^2052^16
 ;;^UTILITY(U,$J,358.3,41874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41874,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,41874,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,41874,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,41875,0)
 ;;=R53.81^^159^2052^23
 ;;^UTILITY(U,$J,358.3,41875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41875,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,41875,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,41875,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,41876,0)
 ;;=R53.83^^159^2052^15
 ;;^UTILITY(U,$J,358.3,41876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41876,1,3,0)
 ;;=3^Fatigue
 ;;^UTILITY(U,$J,358.3,41876,1,4,0)
 ;;=4^R53.83
